Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Potassium clorazepate poisoning |
Causative agent (attribute) |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Accidental potassium clorazepate poisoning |
Causative agent (attribute) |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
|
Intentional potassium clorazepate poisoning |
Causative agent (attribute) |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
|
Potassium clorazepate poisoning of undetermined intent |
Causative agent (attribute) |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Potassium clorazepate adverse reaction |
Causative agent (attribute) |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Potassium clorazepate allergy |
Causative agent (attribute) |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
|
Accidental potassium clorazepate overdose |
Causative agent (attribute) |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Dipotassium clorazepate 7.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
|
Dipotassium clorazepate 15 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
|
Product containing precisely dipotassium clorazepate 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
|
Dipotassium clorazepate 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
|
Dipotassium clorazepate 11.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
|
Clorazepate dipotassium 7.5mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
|
Product containing precisely dipotassium clorazepate 22.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
|
Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
|
Product containing clorazepate dipotassium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
|
Accidental potassium clorazepate poisoning |
Causative agent (attribute) |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Intentional potassium clorazepate poisoning |
Causative agent (attribute) |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Potassium clorazepate allergy |
Causative agent (attribute) |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Chlorazepate dipotassium measurement |
Component |
True |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Dipotassium clorazepate 7.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Dipotassium clorazepate 7.5 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Dipotassium clorazepate 15 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Dipotassium clorazepate 15 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Product containing precisely dipotassium clorazepate 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Product containing precisely dipotassium clorazepate 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Dipotassium clorazepate 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Dipotassium clorazepate 15 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Dipotassium clorazepate 11.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Dipotassium clorazepate 11.25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Product containing precisely dipotassium clorazepate 22.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Product containing precisely dipotassium clorazepate 22.5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Dipotassium clorazepate 7.5 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Dipotassium clorazepate 15 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Product containing precisely dipotassium clorazepate 22.5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Product containing precisely dipotassium clorazepate 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Dipotassium clorazepate 15 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Dipotassium clorazepate 11.25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |
Allergy to dipotassium clorazepate |
Causative agent (attribute) |
False |
Dipotassium clorazepate |
Inferred relationship |
Some |
1 |